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Abstract
Background: Trachoma is thought to be common over large parts of Southern Sudan. However, many areas of the country,
particularly west of the Nile, have not yet been surveyed. The aim of this study was to confirm whether trachoma extends
into Western Equatoria State from neighboring Central Equatoria, where trachoma is highly prevalent, and whether
intervention with the SAFE strategy is required.
Methods and Findings: Population-based cross-sectional surveys were conducted using a two-stage cluster random
sampling method to select the study population. Subjects were examined for trachoma by experienced graders using the
World Health Organization (WHO) simplified grading scheme. Two counties thought to be most likely to have trachoma
were surveyed, Maridi and Mundri. In Maridi, prevalence of one of the signs of active trachoma (trachomatous inflammation-
follicular (TF)) in children aged 1–9 years was 0.4% (95% confidence interval (CI), 0.0%–0.8%), while no children showing the
other possible sign, trachomatous inflammation-intense (TI), were identified. No trachomatous trichiasis (TT) was found in
those aged under 15, and prevalence was 0.1% (95% CI, 0.0%–0.4%) in those aged 15 years and above. In Mundri, active
trachoma was also limited to signs of TF, with a prevalence of 4.1% (95% CI, 1.4%–6.9%) in children aged 1–9 years. Again,
no TT was found in those aged under 15, and prevalence in those aged 15 years and above was 0.3% (95% CI, 0.0%–0.8%).
Conclusion: Trachoma prevalence in the east of Western Equatoria State is below the WHO recommended intervention
threshold for mass drug administration of antibiotic treatment in all villages. However, the prevalence of TF and TT in some
villages, particularly in Mundri County, is sufficiently high to warrant targeted interventions at the community level. These
results demonstrate that trachoma is not a major public health problem throughout Southern Sudan. Further studies will be
required to determine trachoma prevalence in other areas, particularly west of the Nile, but there are presently no resources
to survey each county. Studies should thus be targeted to areas where collection of new data would be most informative.
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Introduction
Trachoma is caused by ocular infection with the obligate
intracellular bacterium Chlamydia trachomatis. Ocular Chlamydia is
spread through contact with eye discharge from the infected
person and through transmission by eye-seeking flies [1]. The
disease is associated with poor personal and environmental
hygiene, in particular limited access to water and sanitation,
overcrowding and poor socioeconomic conditions.
Trachoma is the leading infectious cause of blindness, estimated
to be responsible for 3.6% of blindness worldwide [2]. It is endemic
in 56 countries, mainly in poor rural areas, including parts of
Central and South America, many African countries and some
countries in the EasternMediterranean [3]. However, there is a lack
of information from some major populations, including large parts
of Southern Sudan, which remains an important obstacle to
estimating the disease burden and to the implementation of control
efforts [4]. TheWorld Health Organization (WHO) has identified a
need for more trachoma data, and it is recognized that such data are
necessary for implementation of the SAFE strategy: Surgery for
trichiasis, Antibiotics to treat infection, and Facial cleanliness and
Environmental improvement to reduce transmission [5].
Trachoma has long been known to be prevalent in parts of
Sudan [6,7], but comprehensive data on distribution and burden
particularly in Southern Sudan continue to be limited. To
generate baseline data, the Carter Center and the Ministry of
Health, Government of Southern Sudan (MoH-GoSS), have
jointly conducted prevalence surveys in thirteen sites covering a
large geographical area mostly to the east of the river Nile
[8,9,10,11]. In all of these locations the average prevalence of
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active trachoma (trachomatous inflammation-follicular (TF) and/
or trachomatous inflammation-intense (TI)) in children aged 1–9
years was found to be well above the 10% threshold recommended
by WHO for large-scale SAFE intervention [5,11,12]. Ngondi and
colleagues have used prevalence data from Upper Nile and Jonglei
to estimate that in these two States alone 3.9 million people need
antibiotic treatment and 206,000 people are in need of immediate
trichiasis surgery [9]. These estimates are based on the assumption
that trachoma prevalence is homogenous over large areas, which
remains to be confirmed for Southern Sudan.
In common with other neglected tropical diseases (NTDs) endemic
to Southern Sudan, there is a need to conduct additional surveys to
better understand the epidemiology of trachoma and identify areas
requiring interventions [13]. In Southern Sudan, a National Program
for Integrated Control of NTDs has recently been established,
presenting a new opportunity to contribute towards trachoma control
by integrating annual distribution of antibiotic treatment with mass
drug administration (MDA) of preventive chemotherapy (PCT) for
other common NTDs, namely onchocerciasis, lymphatic filariasis
(LF), soil-transmitted helminth (STH) infection and schistosomiasis
[14,15]. The program has started to operate in geographic areas
where community-directed treatment with ivermectin (CDTI) for
onchocerciasis control has been conducted for a number of years,
because it intends to use the CDTI approach for co-implementation
of other interventions where feasible [16,17].
Western Equatoria State is one of the two States that has been
selected for initial integrated NTD intervention, because it has a large
onchocerciasis focus and a well-established CDTI network, and
anecdotal and past survey data indicate that LF, STH infection and
schistosomiasis are also prevalent [12]. To date there are, however, no
information or data available for this State on the distribution or
prevalence of trachoma. The present study was therefore conducted to
generate baseline data on the prevalence of trachoma in parts of
Western Equatoria State to provide evidence as to whether annual
MDA of PCT should include antibiotic treatment, and to contribute
data to revise mapping of the burden of trachoma in the region [4].
Methods
Study Site and Population
During November 2008, two population-based prevalence surveys
were conducted in Western Equatoria State, which lies in the South-
West of Southern Sudan (Figure 1). The majority of people are
agriculturalist, growing maize, cassava, groundnut, and fruit. The
state capital is Yambio, and the other major towns are Tambura,
Nzara, Maridi and Mundri. The total population of Western
Equatoria State was estimated to be 845,989 in 2008, using data
collected during National Immunization Day. This is approximately
8% of the total population of Southern Sudan, which is estimated to
be around 10 million. One trachoma survey was conducted in
Mundri county and the other in Maridi county (Figure 1). At the time
of the surveys, 186,668 people were estimated to live in Mundri and
186,830 in Maridi; both counties consisted of six payams.
The study followed the standard MoH-GoSS protocol for
trachoma prevalence surveys [18]. The protocol recommends that
population-based prevalence surveys are conducted at county (rather
than payam) level, which is the second (rather than the third)
administrative level; the State being the first administrative level in
Southern Sudan. Estimation at county rather than payam level was
thought to be consistent with WHO guidelines, which recommend
trachoma prevalence be estimated at district level or an administrative
area corresponding to an average population size of 100,000 [19,20].
It was estimated that in each county a total sample size of 2000
people (of all ages and sexes) was required. This allows for an
estimated prevalence of 5% trachomatous trichiasis (TT) in adults
aged 15 years and above (chosen because TT was likely to be the least
prevalent indicator measured) within a precision of 2%, given a 95%
confidence limit and a design effect of 2, and based on the assumption
that adults aged 15 years and above comprise 50% of the population.
In each county 20 villages were sampled with probability
proportional to the estimated population size of the payam,
although not all of the payams in Maridi were accessible.
Households were randomly selected using the sketch map and
segmentation method [21]. All residents of the household were
enumerated, and all those present who gave informed consent
were examined.
Trachoma Grading
Ophthalmic Clinical Officers and General Clinical Officers
from the local payams were trained by an experienced
ophthalmologist (K. Lewis) to use the WHO simplified grading
system [22]. This scheme categorizes trachoma infection accord-
ing to five grades: TF, TI, trachomatous scarring (TS), TT and
corneal opacity (CO). Two stages of assessment were used to select
the best trainees. In the first stage, trainee examiners identified
trachoma grades using the WHO set of trachoma slides [22].
Those examiners who achieved at least 80% agreement then
proceeded to the second stage of field evaluation. During field
evaluation, a reliability study comprising 50 persons of varying age
and sex were selected by the ophthalmologist to represent all
trachoma grades. Each trainee examiner evaluated all 50
participants independently and recorded their findings on a pre-
printed form. Inter-observer agreement was then calculated for
each trainee using the ophthalmologists’ observation as the ‘‘gold
standard.’’ Only trainees achieving at least 80% inter-observer
agreement after the field evaluation were included as graders.
All inhabitants of selected households who provided verbal consent
were examined using a torch and a 26magnifying binocular loupe.
Each eye was first examined for in-turned lashes (TT), and the cornea
was then inspected for CO. The upper conjunctiva was subsequently
examined for inflammation (TF and TI) and scarring (TS). Both eyes
Author Summary
Baseline data on trachoma prevalence is a prerequisite for
intervention. Prior to the present study, all surveys in
Southern Sudan reported trachoma prevalences that
exceeded the threshold for large-scale intervention. This
gave rise to the notion that the disease may be endemic
throughout the country. The present study was conducted
under the auspices of the National Program for Integrated
Control of Neglected Tropical Diseases, to verify whether
prevalences in two counties west of the Nile exceeded the
WHO recommended intervention threshold for mass drug
administration (MDA) of antibiotic treatment. The results
show that trachoma prevalence at county level was below
this threshold. However, prevalences in some communities
within the county were above the threshold, meaning that
they should be targeted with MDA of antibiotics, as well as
with other interventions such as trichiasis surgery, health
promotion and improved water and sanitation. This
finding reminds us of the need for geographical targeting
of resources, both for surveys and subsequent interven-
tion. Current resources are insufficient to conduct popu-
lation-based prevalence surveys for trachoma throughout
Southern Sudan. Further surveys should thus be conduct-
ed in areas where collection of additional information will
be most informative. We propose that a combination of
risk-mapping and rapid assessments is used to identify
such areas.
Trachoma in Southern Sudan
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were examined. Signs had to be clearly visible in accordance with the
simplified grading system in order to be considered present.
Trachoma signs only had to be present in one eye for the person
to be categorized as suffering from a particular grade of trachoma.
Alcohol-soaked cotton swabs were used to clean the examiner’s
fingers between examinations. Individuals with signs of active
trachoma or bacterial conjunctivitis were treated with 1% tetracycline
eye ointment and provided with information on face washing and
good hygiene practices. Patients with TT or other significant eye
conditions were referred to the nearest facility where free surgery is
available (i.e. Juba Teaching Hospital).
Quality Control, Data Entry, and Analysis
The data was initially entered using Personal Digital Assistants
(PDA, Palm Tungsten E2) in the field. A second data entry was
conducted by the Trachoma Control Program, MoH-GoSS using
Microsoft Office Excel. Consistency checks were performed in EpiInfo
version 3.2.2 (Centers for Disease Control and Prevention [http://
www.cdc.gov/EpiInfo]). Range and consistency checks were con-
ducted for all variables. Data were analyzed in STATA 9.0 software
(Stata Corporation, College Station, TX, U.S.A.). Individuals with
missing data on sex and/or age were excluded from the analysis.
For each county, prevalences of trachoma signs were summa-
rized by age, in relation to WHO recommendations for
implementation of trachoma control activities [5]. Unadjusted
exact binomial 95% confidence intervals (CIs) are presented, along
with adjusted 95% CIs that account for potential clustering
obtained using generalized estimating equation (GEE) modeling.
Chi-squared tests, or Fishers test where appropriate, were used to
examine evidence for differences in proportions.
Ethical Considerations
The study protocol received ethical approval from the
Directorate of Research, Planning and Health System Develop-
ment, MoH-GoSS. Clearance to conduct the surveys was obtained
from the State MoH, followed by County Health Departments
and the local government. The study was explained to each
member of the selected households. The household heads were
asked to provide written consent for the entire household to
participate in the study, and each inhabitant of the household who
provided verbal consent was examined. Those individuals who did
not provide verbal consent were not examined. Personal identifiers
were removed from the dataset before analysis.
Results
In the 20 study villages in each county, the number of
households sampled and individuals examined were similar
(Table 1). The average household size in Mundri was larger
Figure 1. Maps showing surveyed counties in Western Equatoria State (hatched), and the prevalence of active trachoma (TF) and of
trichiasis at each study site.
doi:10.1371/journal.pntd.0000492.g001
Trachoma in Southern Sudan
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(p,0.001). There were three missing values for sex in Mundri. Age
data were missing for approximately 10% of individuals in each
county. There was no difference in the sex distribution by county
(p = 0.672), whereas age distribution did differ by county
(p,0.001), with more children aged 1–9 years and fewer people
aged 15 or above in Maridi, compared to Mundri.
Consent refusal was very low; 48 individuals (2.8%) refused
overall, of which 16 (2.5%) were inMaridi and 32 (2.9%) inMundri,
although some enumerated individuals were subsequently unavail-
able for examination. Approximately 90% and 80% of children
aged 1–9 from study villages in Maridi and Mundri were examined
for signs of active trachoma, respectively. Examination data for TS
were available for 80% of individuals inMaridi and 70% inMundri.
Of those aged 15 and above, TT and CO examinations were
conducted in 75% of individuals in Maridi and 65% in Mundri.
Active Trachoma
The overall prevalence of TF (adjusted 95% CI) in children
aged 1–9 years in Maridi was 0.4% (0.0–0.8%) with cases
occurring only in male children (Table 2). In Mundri, the
prevalence of TF (adjusted 95% CI) in children aged 1–9 years
was 4% (1.4–6.9%), with similar prevalence in male and female
children. No cases of TI were found in either county, so
prevalence estimates for active trachoma are the same as for TF.
Trachomatous Trichiasis and Corneal Opacity
For TT, the overall prevalence (adjusted 95% CI) in those aged
15 years and above in Maridi was estimated to be 0.1% (0.0–0.4%)
based on just one female individual with TT (Table 2). In Mundri,
three male individuals were found to have TT leading to a
prevalence estimate of 0.3% (0.0–0.8%). The small number of
individuals with TT also had some degree of corneal opacity. No
trichiasis was found in individuals under the age of 15 in either
county.
Trachomatous Scarring
Little evidence of scarring was observed in either county, the
highest prevalence (adjusted 95% CI) was in individuals aged 15
and over in Mundri; 0.9% (0.2–1.5%).
Intervention Implications
No villages in Maridi had a prevalence of TF above 5%, but one
village did have a prevalence of TT of more than 1% (Table 3,
Figure 1). In Mundri, two villages had a prevalence of TF between
5% and 9% and a further three villages had a prevalence of more
than 10% (Table 3, Figure 1), suggesting a requirement for F and
E components of the SAFE strategy in these five villages along
with annual MDA of antibiotics in the three villages with higher
prevalence. Two additional villages in Mundri had a prevalence of
TT of more than 1% (Figure 1).
Discussion
This study was conducted within the context of scaling up of the
National Program for Integrated Control of NTDs, to decide
whether antibiotic treatment for trachoma should be included in
annual MDA of PCT for other NTDs in Western Equatoria State.
Based on consultation with State and County Health Authorities,
two counties were selected to represent those areas of the State
thought to be worst affected by trachoma. Despite purposefully
selecting these areas, we found that the overall burden of active
trachoma in children aged 1–9 years was below the 10% threshold
recommended by WHO for large-scale MDA of antibiotic
treatment. Similarly, the overall prevalence of TT in people aged
15 years or over was below the recommended 1% threshold for
large-scale SAFE intervention. However, some study villages in
Mundri County did have TF prevalences that exceeded 5%, which
warrants community-wide intervention by means of annual MDA
of antibiotic treatment, health promotion and improvements of
water and sanitation [5]. The three study communities with cases
of trichiasis will need to be provided with access to surgery. It is
likely that other communities, particularly in Mundri County, are
also affected by active trachoma and/or TT and need to be
provided with some or all components of the SAFE strategy.
Community-by-community assessments will be needed to identify
these [5].
The relatively low trachoma prevalences observed in Maridi
and Mundri are in stark contrast to those reported by investigators
who surveyed other parts of Southern Sudan, including two sites
(Tali and Katigiri) adjacent to Mundri that were found to have
72.6% and 50.0% prevalence of active trachoma in children aged
1–9, respectively [9]. In fact, in all other sites previously surveyed
throughout Southern Sudan, prevalence of active trachoma
exceeded the 10% intervention threshold by up to eight times
[8–11]. Present findings thus provide an important contribution to
our understanding of trachoma epidemiology in Southern Sudan,
Table 1. Study population.
Maridi Mundri p-Value*
Villages sampled 20 20
Households sampled 393 400
Median household size (range) 8 (1–26) 10 (2–30) ,0.001
Individuals enumerated 2702 3547
Individuals enumerated with
age and sex data{
2350 3190
Male 1132 1555
,1 year, n (%) 42 (3.7) 66 (4.2) ,0.001
1–9 years, n (%) 598 (52.8) 663 (42.6)
10–14 years, n (%) 112 (9.9) 190 (12.2)
15 & above, n (%) 380 (33.6) 636 (40.9)
Female 1218 1635
,1 year, n (%) 38 (3.1) 59 (3.6) 0.053
1–9 years, n (%) 526 (43.2) 625 (38.2)
10–14 years, n (%) 120 (9.9) 162 (9.9)
15 & above, n (%) 534 (43.8) 789 (48.3)
Individuals examined{
Active trachoma signs (1–9 years)
Male 532 (89.0) 523 (78.9)
Female 464 (88.2) 503 (80.5)
Trachomatous scarring (all ages)
Male 895 (79.1) 1017 (65.4)
Female 975 (80.0) 1225 (74.9)
Trichiasis and corneal opacity ($15 years)
Male 268 (70.5) 348 (54.7)
Female 422 (79.0) 579 (73.4)
*p-value from chi-squared test.
{3 missing values for sex in Mundri, 352 (13.0%) missing values for age in
Maridi, 353 (10.0%) missing values for age in Mundri. Age distribution based on
sex denominators by county.
{data are n (%) of enumerated individuals by sex and county.
doi:10.1371/journal.pntd.0000492.t001
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showing that the disease is not highly endemic throughout the
country and that prevalence can vary considerably between
adjacent counties. Based on this observation it would be unwise to
conclude from our data that the whole of Western Equatoria State
has a low prevalence of trachoma, but given that we purposefully
selected areas that were thought to be worst affected, we may
assume this is the case. To verify this assumption and to decide
whether further population-based prevalence surveys are required
in this State and elsewhere, we propose that more evidence on the
distribution and burden of trachoma is collected through a
combination of risk-mapping, using a global information system
(GIS), and rapid assessments [23]. For the purpose of risk-
mapping, existing trachoma prevalence data for Southern Sudan,
as well as environmental and other potential risk factors [23],
should be incorporated into a model to predict areas at risk of
trachoma transmission. Although GIS has so far not been used to
predict the spatial distribution of trachoma, the approach has
informed targeting of a number of other NTD interventions, such
as schistosomiasis [24–26]. By taking account of the specific
epidemiological characteristics of trachoma, it may be possible to
develop a GIS-based model that could complement the existing
methods for identifying trachoma endemic areas [27].
The challenging operating conditions in Southern Sudan meant
that survey implementation deviated slightly from the approach
Table 2. Prevalence of signs of trachoma.
Trachoma Signs Maridi Mundri
Number (%)
of those
examined
Unadjusted*
95% CI
Adjusted{
Prevalence
(95% CI)
Number (%)
of those
examined
Unadjusted*
95% CI
Adjusted{
Prevalence
(95% CI)
TF (1–9 years)
Overall 4 (0.4) 0.1–1.0 0.4 (0.0–0.8) 41 (4.0) 2.9–5.4 4.1 (1.4–6.9)
Male 4 (0.8) 0.2–1.9 0.7 (0.0–1.6) 22 (4.2) 2.7–6.2 4.4 (0.8–8.0)
Female 0 (0) 0.0–0.8{ - 19 (3.8) 2.3–5.8 3.8 (1.2–6.4)
TI (1–9 years)
Overall 0 (0) 0.0–0.4{ - 0 (0) 0.0–0.4{ -
TS (,15 years) 0 (0) 0.0–0.3{ - 1 (0.1) 0.0–0.4 0.0 (0.0–0.2)
TS ($15 years) 1 (0.1) 0.0–0.8 0.1 (0.0–0.4) 8 (0.9) 0.4–1.7 0.9 (0.2–1.5)
TT (,15 years) 0 (0) 0.0–0.3{ - 0 (0) 0.0–0.3{ -
TT ($15 years) 1 (0.1) 0.0–0.8 0.1 (0.0–0.4) 3 (0.3) 0.0–0.9 0.3 (0.0–0.8)
CO1 (,15 years) 0 (0) 0.0–0.3{ - 0 (0) 0.0–0.3{ -
CO1 ($15 years) 1 (0.1) 0.0–0.8 0.1 (0.0–0.4) 3 (0.3) 0.0–0.9 0.3 (0.0–0.8)
TF = follicular trachoma, TI = inflammatory trachoma, TS = trachomatous scarring, TT = trichiasis, CO = corneal opacity.
*Exact binomial confidence intervals.
{Adjusted estimates obtained using generalised estimating equation (GEE) modelling.
{97.5% one-sided confidence interval; GEE did not converge.
1Trachoma related corneal opacity: only participants with CO and TT were considered to have trachoma related CO.
doi:10.1371/journal.pntd.0000492.t002
Table 3. Community prevalence by county.
Villages sampled Maridi Mundri
20 20
n (%)
Prevalence if above
threshold* n (%)
Village prevalence if
above threshold*
TF in children 1–9 years 0% 17 (85.0%) - 8 (40.0%) -
,5% 3 (15.0%) - 7 (35.0%) -
5–9% 0 (0) - 2 (10.0%) 5.4%, 7.8%
10–19% 0 (0) - 2 (10.0%) 13.0%, 16.3%
20–25% 0 (0) - 1 (5.0%) 22.9%
TT in those 15 years & above 0% 19 (95.0%) - 19 (90.0%) -
,1% 0 (0) - 0 (0) -
$1% 1 (5.0%) 2.1% 2 (10.0%) 3.0%, 3.5%
TF= follicular trachoma, TT = trichiasis.
*Threshold for implementation of trachoma control activities according to WHO guidelines; i.e. implementation of trachoma control activities is prioritized in
communities where the prevalence of active trachoma in children aged 1–9 years is 10% or higher or where the prevalence of trichiasis in people aged 15 years and
over is 1% or higher [5].
doi:10.1371/journal.pntd.0000492.t003
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recommended in the national trachoma survey protocol [18]. Due
to a lack of security not all of the payams in Maridi were
accessible. In both counties we had to exclude some of the
randomly selected village, because they were inaccessible due to
flooding or impassable roads, or we found that they were more
than a 45-minute walk from the nearest vehicle access point.
Furthermore, some villages that were recorded on the maps
developed by the United Nations Joint Logistics Coordination and
International Mapping Unit no longer existed. As we had used
these maps to select villages, it meant that not all of the sites from
our initial random selection could be surveyed. If a village was
known to be inaccessible or non-existent in advance, an alternative
site was randomly selected. If the village was found to be
inaccessible or non-existent on arrival, an alternative site close to
that geographic location was selected.
This slight deviation from a true random selection of villages may
have introduced bias, thus affecting our estimation of overall
trachoma prevalence in a county. For example, overall prevalence
may have been underestimated if the villages inaccessible at the time
of the survey had poorer access to healthcare, so that residents were
less likely to have been treated for trachoma. However, our field
observations indicated that healthcare provision was uniformly poor
across the survey area, with no major variations in access or quality
between villages. Healthcare delivery largely consisted of commu-
nity health workers with little equipment or training. Because few of
the randomly selected villages were excluded, we consider it unlikely
that any significant bias was introduced to the overall estimate of
trachoma prevalence for either county.
Of the individuals living in households recruited into the study,
the overall percentage examined was 68.9% in Mundri and 76.2%
in Maridi. This rate was somewhat less than that reported by other
investigators, who examined 85%–90% of registered household
occupants during surveys in other parts of Southern Sudan
[10,11,28]. The main reason for non-response was that individuals
were not present at the time of the survey; unfortunately it was not
possible to follow these up due to the difficult operating conditions.
The majority of those absent were men aged 15 years and above,
meaning that significantly more females than males in older age
groups were examined in both counties. Such absenteeism may
have biased our overall findings, possibly resulting in an
overestimate of trachoma prevalence if, for example, males with
good eyesight had been more able to leave home. We were unable
to investigate this further, because trachoma was not sufficiently
endemic to make a valid comparison of prevalence between males
and females. Lastly, we had to exclude some incomplete eye
examinations from the analysis, as some individuals withdrew their
consent after examination of the first eye. This was more common
in children, and might have led to an underestimation of TI and
TF infection, particularly if infected individuals experienced more
discomfort during examination and were thus more likely to
withdraw their consent.
Despite these operational limitations and their potential
implications for the precision of our estimates, the low trachoma
prevalence found clearly shows that annual MDA with antibiotics
does not need to be targeted at all villages in the two counties, but
only at a selection within these. This means that integration of
trachoma treatment as part of annual MDA for the other diseases
targeted by the National Program for Integrated Control of NTDs
would not be practical.
There are a number of possible explanations for the difference
in the results of the present study when compared to those of other
investigators. Firstly, previous surveys on trachoma in Southern
Sudan were conducted in areas where health workers had already
reported trachoma to be a cause of blindness. In contrast, the
selection of the present study sites was not based on such reports,
but on the assessment of State and County health staff as to which
areas are worst affected by trachoma, in a State that generally
experiences little demand for trachoma treatment services. This
difference in the selection of the survey area will have affected our
results. Whereas investigators of previous studies had good
evidence that trachoma was endemic before they undertook the
surveys, there was no indication that it constituted a major public
health problem in Mundri or Maridi.
The second difference between the present study and those
previously conducted in Southern Sudan is that we used different
survey staff. The graders used in the present study may have
under-graded symptoms, when compared to grading done in
previous studies, which in turn may have led to systematic bias in
clinical grading. This could explain why there were seemingly no
cases of active trachoma in villages with TT and vice versa
(Figure 1). Though we can not exclude this possibility, it may also
be possible that these findings are the result of extensive
population movement in Southern Sudan, with the few diagnosed
TT cases maybe having moved relatively recently from trachoma
endemic areas to these three villages. It is unlikely that the absence
of active cases in villages with TT is a result of recent
socioeconomic development and associated improvements in
access to safe water and proper sanitation, as such development
is proceeding very slowly throughout the country.
To minimize the possibility of under- or over-grading of
trachoma symptoms, we ensured that the clinical scoring
conducted by our graders was consistent and agreed with a
standardized set of photos. We also assessed the feasibility of
verifying the graders findings by taking photographs and/or
samples for analysis by nucleic acid amplification tests as suggested
elsewhere [29], but established that both methods were beyond
what was feasible with existing resources and in an environment
with no infrastructure. For future trachoma studies, the possibility
of implementing either or both of these two complementary
approaches should be reassessed and budgeted for.
The third potential variation between the current and previous
surveys is a difference in the livelihoods between the populations
sampled, as well as their hygiene behavior. A detailed analysis of
trachoma risk factors in the previously sampled populations [30]
showed that cattle ownership was common (69.2% overall), and
increased the risk of trachoma infection, along with other factors
such as unclean face, face washing less than twice a day and high
household fly density. The geographical area visited during the
present surveys, however, is known to be largely inhabited by
agriculturalists. This was confirmed in our household surveys, which
showed that 86.7% and 75.3% of households in Maridi and
Mundri, respectively, were mainly involved in agriculture (data not
shown). The absence of large amounts of livestock and their dung
might have resulted in lower fly densities and hence less
transmission. In addition, Ngondi and colleagues [30] reported
anecdotal evidence that people keeping cattle also dispose of human
feces in the cattle pens, hence providing an even more favorable
breeding environment for flies. As we did not investigate behavior in
sufficient detail, this and other potential differences in daily hygiene
and sanitation behavior between agriculturalist and pastoralist
tribes in Southern Sudan remains hypothetical. Further sociological
studies would help to better understand such differences and their
potential implications on trachoma transmission [30].
Above explanations are likely to account for only part of the
differences between study sites in Southern Sudan. The impor-
tance of geographical, climatic and socio-economic determinants,
for example, warrants further investigation. Their possible
association in Southern Sudan has not been sufficiently
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researched, although an earlier study in the Sudan provides
evidence for an inverse correlation of TF/TI prevalence with
humidity and rainfall [7].
Conclusion
The low prevalence of trachoma observed in the present study
and the lack of reported cases from other counties in Western
Equatoria State suggest that trachoma is also unlikely to be highly
endemic in those counties not surveyed to date. Although this
needs to be verified, we do not consider this a current priority.
Instead, the limited resources available for surveys should be used
to generate baseline data for counties where trachoma is known to
be a problem, but where there is no data to monitor interventions.
Among these, counties where intervention is feasible (in terms of
access and funding) should be prioritized.
In addition, it will be important to complete the picture of
trachoma epidemiology in Southern Sudan, to get a better
understanding of the scale of the burden and the resources
required to eliminating blinding trachoma from Southern Sudan
by 2020. In the interest of conserving scarce resources, we propose
that trachoma distribution is assessed in stages. In the first stage,
the large amount of existing prevalence data should be used to
develop a trachoma risk map for the whole of Southern Sudan,
which will not only indicate where trachoma is certain to be highly
endemic but also where prediction of endemicity is rather
uncertain. Based on this information, rapid assessments should
then be conducted in those areas with no data and high
uncertainty of the level of endemicity. Based on the outcome of
such assessments it can be decided whether one should move to
the third stage - detailed prevalence surveys - to provide baseline
data. In an iterative process, the data generated through rapid
assessments and additional prevalence surveys should be used to
verify the predictions of the risk map model, and fine tune and
improve these, including estimates of the national trachoma
burden.
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